Back To: Home



June 6-7, 2013
European Lab Automation - Hamburg, Germany

June 12-15, 2013

More Events
Name:
Company:
Email:
 
 
 
The LightCycler® 1536 System. Enabling endogenous gene expression.

University of Dundee granted $15.7 million from Wellcome Trust
April 2012
SHARING OPTIONS:

DUNDEE, U.K—The Wellcome Trust has granted the University of Dundee more than $15.7 million to support research into highly neglected parasitic diseases. The deal includes $13.5 million of support for a partnership with GlaxoSmithKline PLC (GSK) for new drug treatments, in which the Drug Discovery unit at Dundee will collaborate with GSK’s Kinetoplastids Discovery Performance unit at the company’s Tres Cantos Medicines Development Campus in Spain. The partners will seek to develop treatments for leishmaniasis, Chagas disease and African sleeping sickness, with the goal of having at least one treatment for one of the diseases in the next five years. Work has been underway at the university on a treatment for African sleeping sickness for the past five years, and the university says there have been encouraging developments in terms of potential treatments for leishmaniasis.

Back

cISBIO

ATCC


Beckman

R&D Systems

INDIGO

Singulex
CONTACT US
Drug Discovery News
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2013 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.